浙江省成年人血脂异常知晓率、治疗率和控制率的影响因素分析

doi:10.19485/j.cnki.issn2096-5087.2020.12.010

Preventive Medicine

2020, Vol. 32

Issue (12): 1230-1235 DOI: 10.19485/j.cnki.issn2096-5087.2020.12.010

Current Issue | Archive | Adv Search

Abstract
Figure/Table
References
Related Citation (2)

[1] REN J,GRUNDY S M,LIU J,et al.Long-term coronary heart disease risk associated with very-low-density lipoprotein cholesterol in Chinese:the results of a 15-year Chinese multi-provincial cohort study(CMCS)[J]. Atherosclerosis,2010,211(1):327-332.
[2] STONE N J,ROBINSON J G,LICHTENSTEIN A H,et al.2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults:a report of the American Collge of Cardiology/American Heart Association Task Force on Practice Guidelines[J]. Circulation,2014,129(S2):1-45.
[3] PAN L,YANG Z,WU Y,et al.The prevalence,awareness,treatment and contol of dyslipidemia among adults in China[J]. Atheroselerosis,2016,248:2-9.
[4] 邵永强,樊丽辉,李江峰,等. 温州市成人血脂异常流行特征分析[J]. 预防医学,2016,28(10):1000-1004.
[5] 李辉,段东辉,王永,等. 宁波市居民血脂异常及影响因素分析[J]. 预防医学,2019,31(5):474-481.
[6] 刘立群,俞敏,钟节鸣,等. 浙江省居民营养与健康状况调查[J]. 浙江预防医学,2007,19(3):1-2.
[7] 卢伟,刘美霞,李锐,等. 上海15~74岁居民代谢综合征的流行特征[J]. 中华预防医学杂志,2006,40(4):262-268.
[8] 武鸣,郭志荣,杨婕,等. 江苏省代谢综合征相关危险因素研究[J]. 中华流行病学杂志,2007,28(6):536-539.
[9] 王增武,王馨,李贤,等. 中国35~59岁人群代谢综合征患病率及其变化[J]. 中华流行病学杂志,2009,30(6):596-600.
[10] 中国成人血脂异常防治指南修订联合委员会. 中国成人血脂异常防治指南(2016年修订版)[J]. 中华心血管病杂志,2016,44(10):833-853.
[11] 李剑虹,王丽敏,米生权,等. 2010年我国成年人血脂异常知晓率和治疗率及控制率调查[J]. 中华预防医学杂志,2012,46(8):687-691.
[12] HE H,YU Y Q,LI Y,et al.Dyslipidemia awareness, treatment, control and influence factors among adults in the Jilin province in China: a cross-sectinal study[J]. Lipids Health Dis,2014,3(13):122-130.
[13] 谢谨,董忠,李航,等.北京市18~65岁居民血脂异常的知晓率、治疗率和控制率及知晓率影响因素分析[J].中国慢性病预防与控制,2017,25(7):489-493.
[14] 胡文斌,张婷,张小花,等.2016年昆山市居民血脂异常患病率、知晓率及其影响因素分析[J].中华内分泌代谢杂志,2018,34(7):573-577.
[15] LI X Y,BAO Y Z,YANG F Y.Control rate and effective control rate of dyslipidemia and their influence factors among residents in Laiwu city[J]. Chin J Public Health,2012,28(10):1367-1369.
[16] FU Y Y,YU J M,WANG J S,et al.Prevalence and awareness of dyslipidemia among overweight and obese population in Beijing community[J].Chin J Cardiol,2010,38(6):562-566.
[17] ALKERWI A,PAGNY S,LAIR M L,et al.Level of unawareness and management of diabetes,hypertension,and dyslipidemia among adults in Luxembourg:funding from ORISCAV-LUX study[J]. PLoS One,2013,8(3):e57920.
[18] LEVENTHAL A M,HUH J,DUNTON G F.Clustering of modifiable biobehavioral risk factors for chronic disease in US adults:a latent class analysis[J]. Perspectives public health,2014,134(6):331-338.
[19] PRONK N P,ANDERSON L H,CRAIN A L,et al.Meeting recommendations for multiple healthy lifestyle factors. Prevanlence,clustering,and predictors among adolescent,adult,and senior health plan members[J]. Am J Pre Med,2004,27(2):25-33.
[20] 戚圣香,洪祈,王志勇,等. 南京市成人中心性肥胖与心血管疾病危险因素聚集及患病的关系[J]. 中国慢性病预防与控制,2018,26(5):346-350.
[21] DESPRES J P,LEMIEUX I.Abdominal obesity and metabolic syndrome[J]. Nature,2006,444(7121):881-887.